Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_874_Библиотеки_им_академика_М_И_Перельмана.pdf
506
Fig. 33.6 Robotic repair
of recurrent hiatal hernia
following previous robotic
repair. Improved visibility
and dexterity are benecial
with complex foregut
reoperations
J. A. Bilezikian et al.
5-year retrospective review of 200 patients undergoing primary or reoperative
robotic antireux surgery, the robotic approach showed minimal morbidity [12].
Open repair is usually selected as the approach of choice in these reoperations
due to better exposure of the operative eld compared with laparoscopic repair.
Better visualization using the robotic approach may obviate this as a benet of open
surgery. A recent study by Tolboom etal. included 75 patients at a single institution
undergoing redo surgery for recurrent GERD-related symptoms or dysphagia [16].
Thirty patients underwent a standard laparoscopic redo operation, and the remaining 45 patients underwent a robot-assisted operation [16]. The robotic group had
more patients who had undergone an open index procedure [16]. This study demonstrated that early postoperative complication rates were similar and that conversion
to open surgery occurred more often when using laparoscopic approaches compared
with robotic approaches. [16] Robotic repair for reoperation of antireux surgery
has several benets to the surgeon experienced in minimally invasive/robotic techniques (Fig.33.6).
33.9 Conclusions
As surgeons strive to optimize surgical technique and patient outcomes, reoperations for recurrent diaphragmatic hernias are inevitable. Repairs fail due to technical
failure factors and risk factors inherent in improper patient selection. The decision
whether to reoperate depends on the patient’s severity of symptoms and patientrelated risk factors. Although the optimal approach has not been categorically demonstrated, most surgeons use an open approach while some choose laparoscopic or
robotic approaches. Ultimately, this selection is based on surgeon experience with
the different approaches and patient-specic factors such as complexity of the original operation and type of wrap performed. While there is some evidence suggesting
that robotic repair of recurrent diaphragmatic hernia has some benets, large, prospective, randomized studies are needed to identify long term outcomes.
33 Reoperation After Robotic Diaphragmatic Hernia Repair
507
References
1. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD, etal. Guidelines
for surgical treatment of gastroesophageal reux disease. Surg Endosc. 2010;24:2647–69.
https://doi.org/10.1007/s00464-010-1267-8.
2. Lanfranco AR, Castellanos AE, Desai JP, Meyers WC.Robotic surgery: a current perspective.
Ann Surg. 2004;239:14–21. https://doi.org/10.1097/01.sla.0000103020.19595.7d.
3. Draaisma WA, Buskens E, Bais JE, Simmermacher RK, Rijnhart-de Jong HG, Broeders IA,
etal. Randomized clinical trial and follow-up study of cost-effectiveness of laparoscopic versus conventional Nissen fundoplication. Br J Surg. 2006;93:690–7. https://doi.org/10.1002/
bjs.5354.
4. Markar SR, Karthikesalingam AP, Hagen ME, Talamini M, Horgan S, Wagner OJ.Robotic vs.
laparoscopic Nissen fundoplication for gastro-oesophageal reux disease: systematic review
and meta-analysis. Int J Med Robot. 2010;6:125–31. https://doi.org/10.1002/rcs.309.
5. Morino M, Pellegrino L, Giaccone C, Garrone C, Rebecchi F.Randomized clinical trial of
robot-assisted versus laparoscopic Nissen fundoplication. Br J Surg. 2006;93:553–8. https://
doi.org/10.1002/bjs.5325.
6. Muller-Stich BP, Reiter MA, Wente MN, Bintintan VV, Koninger J, Buchler MW, et al.
Robot-assisted versus conventional laparoscopic fundoplication: short-term outcome of a
pilot randomized controlled trial. Surg Endosc. 2007;21:1800–5. https://doi.org/10.1007/
s00464-007-9268-y.
7. Muller-Stich BP, Reiter MA, Mehrabi A, Wente MN, Fischer L, Koninger J, etal. No relevant
difference in quality of life and functional outcome at 12 months’ follow-up-a randomised
controlled trial comparing robot-assisted versus conventional laparoscopic Nissen fundoplication. Langenbeck's Arch Surg. 2009;394:441–6. https://doi.org/10.1007/s00423-008-0446-8.
8. Rebecchi F, Allaix ME, Morino M.Robotic technological aids in esophageal surgery. J Visc
Surg. 2017;3:7. https://doi.org/10.21037/jovs.2017.01.09.
9. Jensen JS, Antonsen HK, Durup J.Two years of experience with robot-assisted anti-reux
surgery: a retrospective cohort study. Int J Surg. 2017;39:260–6. https://doi.org/10.1016/j.
ijsu.2017.02.014.
10. Stein HJ, Feussner H, Siewert JR.Failure of antireux surgery: causes and management strate-
gies. Am J Surg. 1996;171:36–9. https://doi.org/10.1016/S0002-9610(99)80070-1.
11. Awais O, Luketich JD, Schuchert MJ, Morse CR, Wilson J, Gooding WE, etal. Reoperative
antireux surgery for failed fundoplication: an analysis of outcomes in 275 patients. Ann
Thorac Surg. 2011;92:1083–9. https://doi.org/10.1016/j.athoracsur.2011.02.088.
12. Elmously A, Gray KD, Ullmann TM, Fahey TJ, Afaneh C, Zarnegar R.Robotic reoperative
anti-reux surgery: low perioperative morbidity and high symptom resolution. World J Surg.
2018;42(12):4014–21. https://doi.org/10.1007/s00268-018-4708-5.
13. Ceccarelli G, Patriti A, Biancafarina A, Spaziani A, Bartoli A, Bellochi R, etal. Intraoperative
and postoperative outcome of robot-assisted and traditional laparoscopic Nissen fundoplication. Eur Surg Res. 2009;43:198–203. https://doi.org/10.1159/000223751.
14. Heemskerk J, van Gemert WG, Greve JW, Bouvy ND. Robot-assisted versus conventional
laparoscopic Nissen fundoplication: a comparative retrospective study on costs and time consumption. Surg Laparosc Endosc Percutan Tech. 2007;17:1–4. https://doi.org/10.1097/01.
sle.0000213756.76761.b7.
15. Nakadi IE, Melot C, Closset J, DeMoor V, Betroune K, Feron P, etal. Evaluation of da Vinci
Nissen fundoplication clinical results and cost minimization. World J Surg. 2006;30:1050–4.
https://doi.org/10.1007/s00268-005-7950-6.
16. Tolboom RC, Draaisma WA, Broeders IA. Evaluation of conventional laparoscopic versus
robot-assisted laparoscopic redo hiatal hernia and antireux surgery: a cohort study. J Robot
Surg. 2016;10:33–9. https://doi.org/10.1007/s11701-016-0558-z.
Index
A
Abdominal cavity, 332, 334
Abdominal cavity volume (VAC), 246
Abdominal perineal excision (APE), 197
Abdominal wall reconstruction (AWR), 135
ECS, 319
Abdominoperineal excision (APE), 209
Abobotulinumtoxin A, 232
Absorbable synthetic biomaterials, 57–60
AbsorbaTack, 127, 128
AccuMesh Positioning System, 107, 109
Acetaminophen, 43, 47, 184
Acute open abdomen, 237
Adhesiolysis, 280–282, 293
Adhesix, 92, 105
Adverse events
DVT, 420, 421
HAP, 421
hematomas, 418, 419
hiatal hernias (see Hiatal hernias)
intra-abdominal adhesions, 419
intraoperative complications, 418
linea alba and extraperitoneal placement, 417
minimally invasive procedures, 422
pain, 420
postoperative complications, 418
pulmonary embolism, 420, 421
recurrence, 420
seromas, 418
system malfunction, 421
wound infection, 418
AESOP, see Automated Endoscopic System
for Optimal Positioning (AESOP)
ALF-X Robotic Surgical System, 18
AlloMax Surgical Graft, 62
Alvimopan, 42, 43
Angelchik device, 475
Angimesh R2, 82
Angimesh R2-1, 84
Angimesh R2-9, 85
Anterior component separation (ACS)
Anterior superior iliac spine (ASIS), 180,
Anticoagulated patients, 138
Antireux surgeries, 475
Archimedes theory, 246
Arthrobot (Vancouver BC), 8
Association of Program Directors for Colon
Automated Endoscopic System for Optimal
B
Bard mesh, 66, 68
Bard Soft mesh, 67, 69
Basic Evolution mesh, 66, 68
Basic mesh, 66, 67
Before Common Era (BCE) to Common Era
Bilateral Dysport
Bilateral inguinal hernia repair, 81
Bilateral inguinal hernias, 138
Bio-A Hiatal, 125
Bio-A product, 58, 64, 125
BioDesign Hernia Grafts, 62
Biodesign Hiatal Hernia Graft, 125
Biomesh A2, 82
Biomesh P1, 69
Bladder injury, 216
Bleeding-hematoma, 298–299
Bochdalek hernia, 439, 440, 442
Body mass index (BMI), 40
Borchard’s triad, 472
Botox, 191, 232, 237, 239
technique, 319, 352
357–358
and Rectal Surgery (APDCRS), 32
Positioning (AESOP), 11–13, 15
(CE), 4
®
, 239
© Springer Nature Switzerland AG 2019
K. A. LeBlanc (ed.), Robotic Assisted Hernia Repair,
https://doi.org/10.1007/978-3-030-23025-8
509
510
Index
Botulinum toxin, 231
BTA, 238
abdominal wall, closure of, 238
benets, 238
and PPP, 237
timing of injection, 237
ventral/incisional hernia repair, 236, 237
data and outcomes, 236
existing clinical applications, 233–234
hernia surgery, applications in, 234, 235
pharmacology, 231, 232
safety considerations in abdominal
hernia use, 239, 240
technique of injection
abdomen and bilateral anks, 235
anatomy, 235
BTA, units of, 236
techniques and formulations, 238, 239
Botulinum toxin A (BTA), 191, 235, 236,
238, 239
abdominal wall, closure of, 238
and PPP, 237
benets, 238
timing of injection, 237
ventral/incisional hernia repair, 236, 237
Bovine products, 61
Bowersox MEDFAST-to-MASH procedure, 13
TM
Bravo
ph study, 480
BTA, see Botulinum toxin A (BTA)
Bulev B, 67, 70
Bulev UL, 67, 70
Burping, 263
C
Cadaveric products, 62
CapSure, 129, 130
Carbon ber, 56
Cathode ray tubes (CRT), 6
Cellis, 62
Cellulose, 55
Chronic pain, 136, 153, 185
anatomic considerations, 153–155
laparoscopic retroperitoneal triple
neurectomy, 159–161
neurectomy after robotic-assisted
preperitoneal inguinal hernia
repair, 158
neuropathic pain
conservative management of, 155
surgical management of, 156
open extended triple neurectomy, 158, 159
orchialgia, 161–162
after ventral hernia repair, 156–158
Chronic postherniorrhaphy inguinal pain
(CPIP), 154
ClearMesh Composite (CMC), 114
Clostridium botulinum, 231
Colostomy mesh, 122
Combi Mesh Plus, 114, 115
Component separation techniques (CST),
244, 245
Composix E/X, 115
Composix L/P, 114–116
Composix L/P mesh with Echo PS, 116
Composix product, 117
Computer Motion’s Zeus, 14
Condensed polytetrauoroethylene (cPTFE), 90
Cooper’s ligament, 213
Cord lipomas, 180
Cortiva, 62
CO3+, 99
CO3A, 99
C-QUR CentriFX, 98, 100
C-QUR FX, 106, 107
C-Qur Mosiac, 106, 107
C-QUR V-Patch, 108
Creutzfeld-Jacobs disease, 56
Critical View of the Myopectineal Orice (CV
of the MPO), 180
Cruraplasty, 482
CST, see Component separation
techniques (CST)
Curvilinear peritoneal incision, 179
D
da Vinci Si surgical system, 17, 359
Bochdalek hernia, 441
Morgagni hernia, 440
da Vinci S surgical system, 15
da Vinci surgical system, 18, 19, 21, 23,
170, 439
patient cart, 171
surgeon console, 171
vision cart, 172
da Vinci X surgical system, 15
da Vinci Xi surgical system, 15, 17, 179, 359
Bochdalek hernia, 442
Morgagni hernia, 440
Decompressive laparotomy, 238
Deep venous thrombosis (DVT), 420, 421
Defense Advanced Research Projects Agency
(DARPA), 10, 11
Degrees of freedom (DOF), 7, 11
Denervation hernia, 386, 393
DermaMatrix, 62
Diabetes mellitus (DM), 356
Index
511
Diastasis recti, see Rives-Stoppa repairs
Diazepam, 47
Double-dock technique, rTARs, 359
DualMesh, 83, 84, 87, 88
DualMesh Plus, 84–88
DualMesh PLUS with Holes, 87, 88
Dulex, 88, 89
Dural homograft, 56
DynaMesh IPOM, 116
DynaMesh-IPST, 122, 123
Dynamesh PP—Light, 68, 71
Dynamesh PP—Standard, 68, 71
Dysphagia, 470
Dysport, 232, 239, 240
E
Easy-Catch EC device, 117
Easy Pro Composite Mesh, 106, 108
Easy Prothes, 68
Easy Prothes 3D Mesh, 100
Easy Prothes lightweight, 71
Easy Prothes mediumweight, 71
Easy Prothes Partially Absorbable, 93, 94
Easy Prothes Partially Absorbable 3D Mesh, 99
Electroencephalograms (EEG), 6
Electro Light Sensitive with Internal and
External Stability (Elsie), 6
Electromechanical Robot (Elmer), 6
Endoscopic component separation (ECS)
ACS technique, 319, 320
contraindications, 320, 321
evaluation, 329
indications, 320
operative technique
modied subfascial approach, 322–324
subcutaneous CS approach, 323–328
transfascial approach, 321, 322
preoperative preparation, 321
Ramirez approach, 320
ventral hernias, 319
Endoscopy, 13
Enhanced recovery after surgery (ERAS)
protocols
components, 37
implementation of, 46
intra-operative measurements
perioperative antibiotics, 42
postoperative intestinal function
improvement, 42, 43
skin preparation and decolonization
protocols, 42
SSI, 42
long-term benets of, 47, 48
measuring quality in hernia surgery, 45
outcomes with, 46, 47
patient care, 37
patient selection, 45, 46
post-operative measurements
abdominal binders and early
mobilization, 43
early enteral feeding, 45
multimodal pain control, 43, 44
pre-operative measurements
diabetes optimization, 40, 41
nutritional optimization, 41
prehabilitation, 41, 42
smoking cessation, 39, 40
weight loss, 40
surgical stress, 37
wound complications, 39
Enhanced-view totally extraperitoneal
(eTEP)
lower midline defect, 345–347
operating room setup and patient
positioning, 339, 341
upper midline defect, 341, 342, 344, 345
Epigastric pain, 192
Esophageal perforation, 469
Expanded polytetrauoroethylene (ePTFE)
prostheses, 83, 87, 88, 112, 116,
117, 120, 121
Extended-view totally extraperitoneal (eTEP)
approach, 154, 401
External oblique aponeurosis, 325, 327
Extralevator abdominal perineal excision
(ELAPE), 197, 209
Extraperitoneal injury, 216
F
FasTouch, 128, 130
FasTouch absorbable, 131
FasTouch permanent, 130
Femoral hernias, 139
Femoral nerve injury, 215
Fixation devices, 127–131
Flat polyester products, 82
Flex HD Structural, 62
Floppy Nisse fundoplication, 467
Folding mesh with suture, 101, 102
Foley catheter, 172
4D Laparoscopic Mesh, 93, 94
4D Mesh product, 98
4D Ventral, 93, 94
Fundoplication, 475, 486
512
Index
G
Gabapentin, 44, 47
Gas dissection, 204
Gastroesophageal reux disease (GERD)
LINX
®
device, 476
food bolus, passage of, 476
outcomes, 485, 486
postoperative care, 485
preoperative evaluation, 479, 480
surgical indications, 478, 479
surgical technique, 480–485
reoperation, 501
surgical management of, 475
Gastrohepatic ligament, 482
Genitofemoral nerve (GFN), 154, 159, 161, 214
Gentrix Surgical Matrix, 62
Ger technique, 21
Giant inguinal hernias
history, 189, 190
operative techniques, 191–194
post-operative issues and
recommendations, 194, 195
pre-operative preparation, 190, 191
serial plain abdominal X-ray- KUB, 195
Goni Moreno protocol, 245
Gonzalez Hernia Binder technique, 418
Green Telepresence Surgery system, 10, 13
Groin hernia repair, 190
Grynfeltt-Lesshaft triangle, 383
H
Haptic feedback, 31
HD-3D, see High-denition 3-dimensional
(HD-3D) technology
Head-mounted display (HMD), 10
Hematoma, 217
Hermesh 3-8, 68, 72
Hernia defect closure, 296, 297
HerniaMesh products, 119
Herniography, 136
Herniorrhaphy technique, 21, 339
Hiatal hernia repair, 125–127, 475, 479
Hiatal hernias, 60, 457, 458, 485
antireux surgery and procedures, 489
bleeding, 490, 491
intraoperative complications, 490
late complications
abdominal pain, 497
antacid medication, 496
barium swallow series, 496
dysphagia, 497
failed fundoplication, 496
gastric vessels, 497
gastro-esophageal junction, 495
hiatoplasty, 496
manometric testing, 495
mesh erosion, 496
pain, 497
para-esophageal hernia, 495
recurrent reux, 495
symptoms, 497
vagal nerve damage, 497
late complications mesh erosion, 496
organ perforation, 491, 492
postoperative in-hospital complications,
494, 495
vagal nerves and intrathoracic structures,
492–494
Hiatal hernia surgery, chronology of, 476
High-denition 3-dimensional (HD-3D)
technology, 15, 19
Hospital-acquired pneumonia (HAP), 421
Hydromorphone patient-controlled
analgesia, 47
Hyperthermic intraperitoneal chemotherapy
(HIPEC), 431
I
Iliac vein, robotic-assisted repair of, 163
Iliohypogastric nerve (IHN), 154
Ilioinguinal nerve (IIN), 154, 159, 160
iMesh tacker, 129, 131
Immunogenicity, 232
Incisional and ventral hernioplasty with
absorbable barrier, 105–107, 109,
110, 112
Incisional and ventral hernioplasty with
permanent barrier, 112, 113, 116,
117, 119–121
Incisional hernia (IH), 53, 135, 234, 238, 243,
267
age, 430, 431
colorectal liver metastasis, 425
conversion therapy, 425
cytoreductive surgery, 431, 432
defect closure in LVHR, 145
immunosuppresion, 429, 430
incidence, 426
indication for repair, 142
malnutrition, 429
mesh utilization, 144, 145
obesity, 428, 429
operative approach, 143, 144
outcomes of robotic repair, 145, 146
patient-centered outcomes, 432
prehabilitation, 142, 143
Index
513
preoperative imaging, 142
prophylactic mesh placement, 432
randomized controlled trials, 432
size of, 426–428
treatment cost, 140
Incisional hernia repair, 250
BTA, 236, 237
DVT, 420, 421
HAP, 421
hematomas, 418, 419
intra-abdominal adhesions, 419
intraoperative complications, 418
linea alba and extraperitoneal
placement, 417
minimally invasive procedures, 422
pain, 420
postoperative complications, 418
pulmonary embolism, 420, 421
recurrence, 420
seromas, 418
system malfunction, 421
wound infection, 418
Incisional hernias with loss of domain (IHLD),
243, 244, 247, 250, 251, 253
Incisional ventral hernia, 304
Incobotulinumtoxin, 232
Inferior vena cava (IVC), 465
Inguinal hernia anatomy, 211
Inguinal hernia repair, 154, 156–158, 189
Inguinal hernias, 20, 21, 135
anticoagulated patients, 138
bilateral inguinal hernias, 138
®
da Vinci
Surgical System, 170–172
femoral hernias, 139
indications for repair, 135, 136
laparoscopic inguinal hernia repairs,
137, 138
medical comorbidities, 139
obesity, 138
operating room set up
cannulas, 172, 173
patient positioning, 172
RAS team and operating room, 170, 171
robot docking, 173–175
operative approach, 137
preoperative imaging, 136
preperitoneal mesh/lower midline surgery,
139, 140
scrotal/nonreducible hernia, 140
women, 139
InoMesh, 91
Integrated surgical systems, 13
Intellectual property, 13
Intra-abdominal hypertension, 195, 243
Intracorporeal suturing methods, 144
Intra mesh, 117
IntraMesh T1, 117
Intraperitoneal inguinal herniorrhaphy, 21
Intraperitoneal onlay mesh (IPOM), 144, 153,
250, 332
adhesiolysis, 280–282
denition, 278
docking, 280
instrumentation, 280
mesh xation, 282, 283
mesh selection, 282
patient positioning, 279
port defects, 284
postoperative care, 284
preoperative care, 278
retro-rectus repairs, 331
trocar placement, 279, 280
ventral hernia repair, 277
Intuitive Surgical’s EndoWrist technology, 17
IS 180, 117, 118
J
JG inguinal implant, 99, 100
L
Lambert-Eaton syndrome, 232
Lap Progrip Anatomic, 101
Laparoscopic Anderson-Hynes pyeloplasty, 14
Laparoscopic cholecystectomy, 169
Laparoscopic hernia repair, 21
Laparoscopic incisional hernioplasty, 205
Laparoscopic inguinal hernia repairs, 137,
138, 221
Laparoscopic repair, 224, 225
Laparoscopic retroperitoneal triple
neurectomy, 159–161
Laparoscopic surgery, 169
Laparoscopic transabdominal preperitoneal
(lTAPP) hernia repair, 211, 216, 226
Laparoscopic ventral hernia repair (LVHR),
30, 144
defects closure in, 145
Laparoscopy, 19
Large inguinal scrotal hernias, 178
Large ventral hernias, 234
Lateral femoral cutaneous nerve injuries, 161
Learning curve, 31–33
Left lower quadrant (LLQ), 271
Lichtenstein open mesh repairs, 170
Lindbergh Operation, 13
Linea alba, 272
514
Index
®
device, 476, 478
LINX
food bolus, passage of, 476
outcomes, 485, 486
postoperative care, 485
preoperative evaluation, 479, 480
surgical indications, 478, 479
surgical technique, 480–485
Local and regional blocks, 44
Los Angeles Classication, 478
Low urine output, 195
Lower midline defects (upper dock setup),
273, 275
Lumbar hernia
abdominal wall, 394
adhesiolysis, 393
classications, 383, 384
clinical presentation, 386
denervation hernia, 393
fascial defects, 387
general anesthesia, 387
history, 383
mimimally invasive approach, 388, 389
open technique, 388
pathogenesis, 385
preoperative planning, 386, 387
robotic-assisted transabdominal
laparoscopic repair
defect closure, 390, 391
docking, 390
identication, 390
mesh placement and xation, 391, 392
peritoneal closure, 393
trocar placement, 389
subcostal transfascial sutures, 394
subcutaneous tissue, 395
surgical anatomy, 384
transfascial suture xation, 393, 394
LVHR, see Laparoscopic ventral hernia
repair (LVHR)
M
Machina Speculatrix, 6
Magnetic sphincter augmentation,
see LINX
®
device
Malnutrition, 143, 429
Marlex (polyolen) mesh, 21, 189
MASTERS program, 33
Median umbilical ligament, 213
Medical comorbidities, 139
Medical Forward Advanced Surgical
Treatment (MEDFAST), 11
Mega Suture Cut Needle, 183
Mersilene plug and patch graft, 21
Mesh xation, 185
Mesh-related pain, 157
Midline incisional hernia, 199
Mini Nutritional Assessment (MNA), 41
Minimally invasive approach, 3, 19, 259
benets of, 198
Minimally invasive mitral valve surgery
(MIMVS), 14
Mobile Advanced Surgical Hospital
(MASH), 11
Modern Robotic Hernia Surgery, 10
Monopolar shears, 34
Morgagni hernias (MH), 439, 440
cart positioning and robot docking, 448
congenital defect, 445
elective surgical repair, 445
hernia sac, 446
instruments, 453
intraoperative considerations, 451–453
laparoscopy, 445, 446
localization, 445
operating room setup, 448
patient positioning, 449, 450
patient selection, 448
port placement, 449, 450
postoperative care, 454
preoperative evaluation, 447, 448
Motifmesh, 90, 91
Musculofascial tissue strength, 54
MycroMesh, 89
MycroMesh PLUS, 90
Myobloc
®
cleaves, 232
N
Nathanson liver retractor, 481
Neo-fascia, 60
Neurectomy after robotic-assisted
preperitoneal inguinal hernia
repair, 158
NeuroBloc
®
cleaves, 232
Neuropathic pain, 152, 156
conservative management of, 155
surgical management of, 156
Neutralizing antibodies, 232
Nonabsorbable mesh, 253
Non-mesh robotic transabdominal
preperitoneal repairs, 185
Nonmetallic synthetic products, 56
Nonmetallic synthetic prosthetic
biomaterials, 56
Nonreducible hernia, 140
Index
515
Nonsteroidal anti-inammatory drugs
(NSAIDs), 43, 47, 155, 184, 298
Nuclear medicine gastric emptying
evaluation, 479
O
Obesity, 40, 138, 143
incisional hernia, 428, 429
Obstructive sleep apnea (OSA), 356
Omega-3 fatty acid (O3FA), 106
Omyra mesh, 90, 91
Onabotulinumtoxin A, 232
One size ts all approach, 53
Open cut-down (Hasson) technique, 172
Open extended triple neurectomy, 158, 159
Open hernioplasty, 191
Open inguinal hernia repairs, 177
Open repair, 224
Operative triple neurectomy, 158
Optix, 129, 130
Optilene, 68, 72
Optilene elastic, 73
Optilene LP, 73
Oral oxycodone, 47
Orchialgia, 161, 162
Orchitis, 195
Ovitex 1S, 63, 64
OviTex 2S, 63
Ovitex core with polypropylene, 64
Ovitex LPR, 64
P
Paracetamol, 43
Paraesophageal hernias (PEH)
anterior gastropexy with PEG tubes, 469
anterior gastropexy with sutures, 468
clinical outcomes, 471
crural closure, 465, 466
docking, 462, 463
elective repair, 457
esophageal lengthening, 465
fundoplication, 466, 467
hiatal hernias, 457, 458
laparoscopic vs robotic fundoplication, 472
mesh reinforcement, 468
operating room setup, 460
patient positioning, 461
peri-operative complications
bleeding, 470
dysphagia, 470
esophageal perforation, 469
gastric perforation, 470
pneumothorax, 469
reux, 470
vagal injury, 469
posterior gastropexy with sutures, 468
preoperative evaluation, 459, 460
reduction of, 463, 464
relaxing incisions, 465, 466
reoperation, 471
symptomatic presentations, 457
timing and indication, 471, 472
trocar placement, 462
visualization, 463
Parastomal hernia, 122, 199
closure of posterior layer, 404, 405
complications, 406, 407
indications, 400
initial access and retromuscular dissection,
401, 402
keyhole techniques, 399
lateralization of conduit, 404, 405
mesh placement, 406
operating room set up, 400
parastomal defects, 404, 405
postoperative management, 406, 414
preoperative considerations, 400
risk factors, 399
Sugarbaker repair, 400, 407
initial access and technique, 408, 409,
412, 413
operating room set up, 408, 409
TAR, 403
Parietene Composite, 106
Parietene DS, 107, 109
Parietene Flat Sheet, 71, 73
Parietene Lightweight products, 71
Parietene ProGrip, 92, 93, 107
Parietex Anatomic with Suture, 102
Parietex Anatomical Mesh, 99, 101
Parietex Composite Hiatal Mesh, 126
Parietex Composite Optimized, 109
Parietex Composite Parastomal Mesh, 123
Parietex Composite Ventral Patch, 108
Parietex Flat Sheet, 82, 85
Parietex Lap ProGrip Anatomic, 99
Parietex Lightweight Mesh, 83, 85
Parietex Monolament Macroporous, 83, 86
Parietex Optimized Composite, 107
Parietex Parastomal with hole, 123
Parietex Parastomal without hole, 124
Parietex ProGrip, 107
Parietex ProGrip Laparoscopic, 92, 93
Patient-controlled analgesia (PCA), 406
516
Index
Pectineal ligament, 21
Pelvic hernia (PH)
APE, 197
computed tomography, 200
defect closure, 205, 206
dissection/adhesiolysis, 204, 205
docking, 203, 204
drapes and marks, 202
nal view of repair, 207
initiation of surgery, 202
instruments, 204
mesh placement and xation, 206
minimally invasive surgery, benets of, 198
patient position, 199–201
patient’s preparation, 199–201
physical exam, 199
risk factors, 198
robotic approach, 208
surgery complications, 206, 207
surgical technique, 204
symptoms, 198
techniques, 198, 199
Perforator preserving component separation
techniques, 244
Perineal defect, 205
Perineal hernias, 197
Peritoneal ap, 162, 216
Peritoneal pocket hernia (PPH), 217
Peritoneum ap, 172
Permacol, 63
PermaFix, 129, 132
Phasix mesh, 58, 59
Phasix ST mesh, 59, 126
Physical therapy, 485
Plurimesh, 118, 119, 124
Pneumoperitoneum aided hernia repair
preoperation treatment options, 244, 245
progressive preoperative
pneumoperitoneum (PPP), 245,
251, 253
CT scan, 252
CT volumetric measurements, 247
efcacy, 250, 252
herniated volume, percentage of,
247, 248
iterative puncture with a palmer
needle, 249
objectives of, 248
prior evaluation of loss of domain,
245, 246
protocol, 248–250
subsequent reintegration surgery,
tolerance of, 252
surgical repair, minimally invasive, 250,
252, 253
VIH and VAC, 246
Polypropylene materials, 81
Polypropylene plugs and patches, 21
Polytetrauoroethylene (PTFE), 64
Polyurethane (PUR), 98, 104
Polyvinylidene uoride (PVDF), 116–117
Porcine products, 62, 63
Postherniorrhaphy chronic pain, 151
classication, 152
risk of surgery, 156
robotic-assisted surgery for, 162, 164
(see also Chronic pain)
Postherniorrhaphy neuropathic chronic
pain, 153
Postoperative urinary retention (POUR), 183
PPP, see Progressive preoperative
pneumoperitoneum (PPP)
Prehabilitation, 41, 42, 142, 143
Premilene, 71, 74
Premium Laparoscopic Inguinal, 103
Premium mesh, 70
Preperitoneal and retrorectus approaches, 34
Preperitoneal hernia, 226
Preperitoneal mesh/lower midline surgery,
139, 140
PROBOT, 9
Proceed, 109, 110
Proceed Ventral Patch (PVP), 110
Programmable Universal Machine for
Assembly (PUMA), 7
Prograsp, 216
PrograspTM Forceps, 179
Progressive pneumoperitoneum, 191, 192
Progressive preoperative pneumoperitoneum
(PPP), 235, 245, 251, 253
CT scan, 252
CT volumetric measurements, 247
BTA, 237
efcacy, 250, 252
herniated volume, percentage of, 247, 248
iterative puncture with a palmer
needle, 249
objectives of, 248
prior evaluation of loss of domain,
245, 246
protocol, 248–250
subsequent reintegration surgery, tolerance
of, 252
ProGrip products, 92
Prolene, 72, 74, 212
Prolene Soft mesh, 72, 74, 109
Prolite, 72, 75
ProLite Ultra, 72, 75
Prosthetic materials
absorbable synthetic biomaterials, 57–60